Abstract:In this study, we integrated large-scale GWAS summary data and used the predicted transcriptome-wide association study method to discover novel genes associated with osteoporosis. We identified 204 candidate genes, which provide novel clues for understanding the genetic mechanism of osteoporosis and indicate potential therapeutic targets. Introduction: Osteoporosis is a highly polygenetic disease characterized by low bone mass and deterioration of the bone microarchitecture. Our objective was to discover novel candidate genes associated with osteoporosis. Methods: To identify potential causal genes of the associated loci, we investigated trait-gene expression associations using the transcriptome-wide association study (TWAS) method. This method directly imputes gene expression effects from genome-wide association study (GWAS) data using a statistical prediction model trained on GTEx reference transcriptome data. We then performed a colocalization analysis to evaluate the posterior probability of biological patterns: associations characterized by a single causal variant or multiple distinct causal variants. Finally, a functional enrichment analysis of gene sets was performed using the VarElect and CluePedia tools, which assess the causal relationships between genes and a disease and search for potential gene's functional pathways. The osteoporosis-associated genes were further confirmed based on the differentially expressed genes profiled from mRNA expression data of bone tissue. Results: Our analysis identified 204 candidate genes, including 154 genes that have been previously associated with osteoporosis, 50 genes that have not been previously discovered. A biological function analysis found that 20 of the candidate genes were directly associated with osteoporosis. Further analysis of multiple gene expression profiles showed that 15 genes were differentially expressed in patients with osteoporosis. Among these, SLC11A2, MAP2K5, NFATC4, and HSP90B1 were enriched in four pathways, namely, mineral absorption pathway, MAPK signaling pathway, Wnt signaling pathway, and PI3K-Akt signaling pathway, which indicates a causal relationship with the occurrence of osteoporosis. Conclusions: We demonstrated that transcriptome fine-mapping identifies more osteoporosis-related genes and provides key insight into the development of novel targeted therapeutics for the treatment of osteoporosis.

Molecular Genetic Studies of Gene Identification for Osteoporosis

Molecular Genetic Studies of Gene Identification for Osteoporosis: the 2009 Update

Progress in the Study of Molecular Genetics of Osteoporosis

A Road Map for Understanding Molecular and Genetic Determinants of Osteoporosis.

Choice of Study Phenotype in Osteoporosis Genetic Research.

Epigenomic Data Facilitate Genetic Studies for Osteoporosis in Post-Gwas Era

Genetics of Osteoporotic Fracture

New insights into the gene function of osteoporosis.

Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis

Identification of Key Osteoporosis Genes Through Comparative Analysis of Men's and Women's Osteoblast Transcriptomes

Design and Interpretation of Linkage and Association Studies on Osteoporosis

Study on Key Genes and Regulatory Networks Associated with Osteoporosis by Microarray Technology

Related genetic polymorphism of primary osteoporosis

The progress of research on osteoporosis related genes

Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.

An atlas of genetic influences on osteoporosis in humans and mice

Progress of the GWAS related to osteoporosis

Integrating Genome- Wide Association Study with Regulatory SNP Annotations Identified Novel Candidate Genes for Osteoporosis

Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications

Replication Study of Candidate Genes/loci Associated with Osteoporosis Based on Genome-Wide Screening

Unraveling the Unexplored Complexity of Osteoporosis: Deciphering Targeted Therapeutic Strategies Through Integrated Bioinformatics Analysis, Mendelian Randomization, and Drug Interactions